Astrazeneca Pharma India Achieves All-Time High Amid Strong Financial Performance
Astrazeneca Pharma India has achieved an all-time high, driven by strong performance in the pharmaceuticals sector. The company reported significant growth in operating profit and net sales, alongside a high return on equity and low debt-to-equity ratio, reinforcing its position as a leading player in the market.
Astrazeneca Pharma India has reached an all-time high, reflecting its strong performance in the pharmaceuticals and drugs sector. The stock has shown impressive momentum, gaining 7.2% over the past five days and 74.12% over the last year, significantly outperforming the BSE 500 index during this period. Today, Astrazeneca Pharma India recorded a 1.63% increase, contrasting with a slight decline in the Sensex. The stock is currently trading just 0.13% below its 52-week high of Rs 9,135.55, indicating robust market activity.
Key financial metrics highlight the company's strong position, including a remarkable operating profit growth of 40.01% and net sales reaching Rs 440.29 crore. Astrazeneca Pharma India boasts a high return on equity (ROE) of 19.06% and a low debt-to-equity ratio, showcasing effective management efficiency.
The stock's technical indicators remain bullish, supported by positive trends in moving averages and other performance metrics. Astrazeneca Pharma India is ranked among the top 1% of companies evaluated by MarketsMojo, solidifying its status as a leading player in the large-cap segment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
